ARCHIVES

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Administration Plans to Stop Paying Advisors; NIH, HHS to Make Protest

May 6, 1983

DCT Adopts New Unsolicited Contract Review Procedures

May 21, 1976

Exercisers May Have Higher Breast Cancer Survival

October 27, 2006

Cooperative Groups With Cancer Control Contracts Receive Two Year Renewals

March 25, 1983

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Cancer Meetings Listed

November 1, 1996